Skip to content

Anspruch auf Immuntherapeutikum im Off-Label-Use gemäß §2 Abs. 1a SGB V

Unknown authors
Oct 2026 · Medizinrecht · Vol 44, pp. 1117 - 1123 · 0 citations
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.